口腔种植与药物相关性颌骨坏死OA

Medication-related osteonecrosis of the jaw(MRONJ)has emerged as a serious complication associated with antiresorptive therapy and anti-angiogenic therapy,and has received increasing attention in recent years.In implant patients,severe MRONJ can lead to devastating consequences for the jawbone,with few effective preventive strategies currently available.Although a substantial body of literature on MRONJ exists,it often lacks systematic organization.Therefore,this review discusses the definition,incidence,etiology and pathogenesis,staging,diagnostic criteria,histopathological manifestations,risk factors,prevention,and treatment strategies for MRONJ.Special emphasis is placed on the risks and management of peri-implant MRONJ(PI-MRONJ).Despite the lack of consensus on many aspects of MRONJ,the objective discussion in this article presents current research progress to clinicians and provide references for the prevention and treatment of MRONJ and PI-MRONJ.